Caricamento...

Close Correlation of 1‐β‐D‐Arabinofuranosylcytosine 5′‐Triphosphate, an Intracellular Active Metabolite, to the Therapeutic Efficacy of N(4)‐Behenoyl‐1‐β‐D‐arabinofuranosylcytosine Therapy for Acute Myelogenous Leukemia

N(4)‐Behenoyl‐l‐β‐D‐arabinofuranosylcytosine (BHAC), a prodrug of 1‐β ‐D‐arabinofuranosylcy‐tosine, is used effectively for the treatment of leukemia in Japan. BHAC therapy may be more effective if it is delivered in conjunction with monitoring of 1‐β ‐D‐arabinofuranosylcytosine 5′‐tri‐phosphate (ar...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Jpn J Cancer Res
Autori principali: Yamauchi, Takahiro, Kawai, Yasukazu, Goto, Nobuyuki, Kishi, Shinji, Imamura, Shin, Yoshida, Akira, Urasaki, Yoshimasa, Fukushima, Toshihiro, Iwasaki, Hiromichi, Tsutani, Hiroshi, Masada, Mikio, Ueda, Takanori
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Publishing Ltd 2001
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5926845/
https://ncbi.nlm.nih.gov/pubmed/11572766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2001.tb01188.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !